10-K: PureCycle Technologies Faces Going Concern Doubts Despite Operational Progress, Reports \$289 Million Net Loss

PureCycle Technologies reports a significant net loss and faces substantial doubt about its ability to continue as a going concern, despite achieving mechanical completion of its Ironton facility and making progress on operational enhancements.

Summary

• PureCycle Technologies, Inc. (PCT) reported its 10-K filing for the fiscal year ended December 31, 2024.
• The company is focused on commercializing its patented dissolution process to recycle polypropylene waste into PureFive resin.
• PCT achieved mechanical completion of its Ironton Facility in April 2023, with an expected capacity of 107 million pounds per year, but it's not yet operating at full capacity.
• The company's goal is to create a new segment in the global polypropylene market, assisting multinational entities in meeting sustainability goals.
• PCT is planning to build new recycling purification facilities globally, including a multi-line facility in Augusta, Georgia, and a European plant in Antwerp, Belgium.
• The company has a Feed PreP facility operating in Denver, Pennsylvania since October 2024 to supply feedstock to the Ironton Facility.
• PCT is subject to various environmental, health, and safety laws and regulations.
• The company received an additional Letter of No Objection (LNO) from the FDA in June 2024, allowing the use of PureFive resin in contact with all food types under FDA's Conditions of Use A through H.
• As of December 31, 2024, PCT employed 157 team members.
• The company faces risks related to its status as a low revenue early commercial stage company and may never achieve or sustain profitability.
• PCT's outstanding secured and unsecured indebtedness could have a material adverse effect on its business, financial condition, results of operations and prospects.
• Delays in commissioning and obtaining an independent engineers certificate of operational performance at the Ironton Facility or any new project could severely impact PCTs business.
• PCT may be negatively impacted by volatility in the political and economic environment, which could have an adverse impact on PCTs business.
• There is no guarantee the Technology is scalable to commercial-scale profitability.
• The market for PureFive resin is still in the development phase and the acceptance of PureFive resin by manufacturers and potential customers is not guaranteed.
• PCT may not be able to meet applicable regulatory requirements for the use of PCTs PureFive resin in food grade applications.
• PCT is dependent on management and key personnel, and PCTs business would suffer if it fails to retain its key personnel and attract additional highly skilled employees.
• Certain current and former stockholders of PCT have the right to elect a certain number of directors to PCTs board of directors.
• Future offerings of debt or offerings or issuances of equity securities by PCT may adversely affect the market price of PCTs common stock or otherwise dilute all other stockholders.
• PCT may be unable to obtain additional financing to fund the operations and growth of the business.
• PCT had total consolidated debt of $346.6 million as of December 31, 2024.
• PCT reported a net loss of $289.1 million for the year ended December 31, 2024.
• The company's unrestricted liquidity as of December 31, 2024, was $15.7 million, and it had restricted cash of $25.8 million.
• PCT has a $200.0 million revolving credit facility with Sylebra Capital that is currently unused and expires on March 31, 2026.
• The company's management believes that its current level of unrestricted liquidity is not sufficient to fund operations, outstanding commitments, and further its future growth plans.
• The conditions described above raise substantial doubt regarding PCTs ability to continue as a going concern for a period of at least one year from the date of issuance of the consolidated financial statements.
• After considering managements plans to mitigate these conditions, including operational progress and re-marketing of the Bonds, PCT believes this substantial doubt has been alleviated and it has sufficient liquidity to continue as a going concern for the next twelve months.

Sentiment

Score: 3

Explanation: The document presents a mixed picture. While there are positive developments like the FDA approval and expansion plans, the significant net loss, going concern doubts, and operational challenges weigh heavily on the sentiment. The company's reliance on future financing and the risks associated with its business model contribute to a negative outlook.

Positives

• PCT achieved mechanical completion of its Ironton Facility.
• The company is expanding globally with facilities planned in Augusta, Georgia, and Antwerp, Belgium.
• PCT received an FDA LNO in June 2024, expanding the use of PureFive resin for all food types under specified conditions.
• PCT has a $200 million revolving credit facility with Sylebra Capital that is currently unused and expires on March 31, 2026.
• Management believes substantial doubt about PCT's ability to continue as a going concern has been alleviated.

Negatives

• PCT reported a net loss of $289.1 million for the year ended December 31, 2024.
• PCT's unrestricted liquidity as of December 31, 2024, was $15.7 million.
• The company's management believes that its current level of unrestricted liquidity is not sufficient to fund operations, outstanding commitments, and further its future growth plans.
• The conditions described above raise substantial doubt regarding PCTs ability to continue as a going concern for a period of at least one year from the date of issuance of the consolidated financial statements.

Risks

• PCT may never achieve or sustain profitability.
• PCTs outstanding secured and unsecured indebtedness could have a material adverse effect on its business, financial condition, results of operations and prospects.
• Delays in commissioning and obtaining an independent engineers certificate of operational performance at the Ironton Facility or any new project could severely impact PCTs business.
• PCT may be negatively impacted by volatility in the political and economic environment, which could have an adverse impact on PCTs business.
• There is no guarantee the Technology is scalable to commercial-scale profitability.
• The market for PureFive resin is still in the development phase and the acceptance of PureFive resin by manufacturers and potential customers is not guaranteed.
• PCT may not be able to meet applicable regulatory requirements for the use of PCTs PureFive resin in food grade applications.
• PCT is dependent on management and key personnel, and PCTs business would suffer if it fails to retain its key personnel and attract additional highly skilled employees.
• Future offerings of debt or offerings or issuances of equity securities by PCT may adversely affect the market price of PCTs common stock or otherwise dilute all other stockholders.
• PCT may be unable to obtain additional financing to fund the operations and growth of the business.

Future Outlook

PCT expects to seek additional debt or equity financing from outside sources for future growth and investment. The company is focused on improving resin pellet production rates, overall reliability of the Ironton facility and product quality. The company is ramping up its commercialization efforts, which the Company believes should lead to meaningful sales going into 2025.

Industry Context

The document highlights the growing awareness around sustainability and the shift of many multinational companies' strategic focus to sustainability as a key differentiator. PCT intends to provide PureFive resin to a diversified customer base across most end markets. The document also mentions negotiations for a global plastic pollution treaty that addresses the full life cycle of plastic, including its production, design, and disposal are expected to resume in 2025.

Comparison to Industry Standards

• The document does not provide specific comparisons to industry standards or comparable companies.
• It mentions that PCT's PureFive resin compares favorably to virgin polypropylene in common Food & Beverage industry benchmarks, but lacks detailed comparative data.
• The document does not provide specific comparisons to industry standards or comparable projects.

Legal Proceedings

• The company is involved in legal proceedings, including shareholder securities litigation and derivative litigation.
• On December 20, 2024, the Court granted the Defendants' motion to dismiss the Amended Southgate Complaint without prejudice, permitting the plaintiff to file a motion to amend the complaint no later than January 10, 2025.
• On January 13, 2025, the Court dismissed the Amended Southgate Complaint with prejudice.
• On February 18, 2025, the Court issued an Order granting preliminary approval of the Derivative Settlement and scheduling a hearing on the matter for May 1, 2025.

Related Party Transactions

• Affiliates of Pure Plastic are greater than 5% beneficial owners of the Company.
• On May 7, 2024, PCT LLC and Pure Plastic LLC executed a bond purchase agreement.
• On May 10, 2024, Pure Plastic executed a Payoff and Release Letter, which memorialized the exchange of the Companys obligations under the $40 million term loan provided to the Company pursuant to the Term Loan Credit Agreement.
• The Company issued warrants (Series B Warrants) to Pure Plastic pursuant to the Series B Warrant Agreement to satisfy the Prepayment Premium.
• On August 7, 2024, PCT LLC, Pure Plastic, and several other parties reached agreement on terms whereby certain investors purchased approximately $22.5 million in aggregate par amount of Series A Bonds owned by PCT LLC at a purchase price of $800 per $1,000 principal amount.
• The Lenders and their affiliates are greater than 5% beneficial owners of PCT.
• On September 11, 2024, in connection with PCTs offering of Series A Preferred Stock, PCT extended the maturity date of the Revolving Credit Facility to March 31, 2026, in conjunction with the Limited Consent and Sixth Amendment to the Credit Agreement, which also (i) permitted the offering of Series A Preferred Stock; (ii) added PureCycle Augusta, LLC as a Guarantor and a Loan Party thereunder and (iii) added as secured obligations certain obligations in respect of the Series A Preferred Stock, Series C Warrants, and pre-funded warrants owed to the Lenders affiliates.

Stakeholder Impact

• Shareholders face potential dilution from future equity offerings and may experience volatility in the stock price.
• Employees face uncertainty due to the company's financial instability and potential restructuring.
• Customers may be concerned about the reliability of supply given the operational challenges at the Ironton Facility.
• Suppliers may face increased scrutiny and potential delays in payments.
• Creditors face increased risk of default given the company's high debt levels and negative cash flow.

Next Steps

• PCT is currently performing certain operational enhancements that are expected to correct the production issues with the Ironton Facility.
• The Company is ramping up its commercialization efforts, which the Company believes should lead to meaningful sales going into 2025.
• PCT intends to, and has the ability to, re-market based on the need for additional liquidity.
• PCT expects to seek additional debt or equity financing from outside sources for future growth and investment.

Key Dates